azomycin has been researched along with Canine Diseases in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (33.33) | 18.7374 |
| 1990's | 7 (46.67) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Rooster, H; Dierckx, R; Ducatelle, R; Loomans, S; Mees, G; Pauwels, P; Peremans, K; Van Damme, N; Van de Wiele, C; Van Goethem, B; Vangestel, C | 1 |
| Bahia, MT; Gravel, AS; Lima, WG; Martins, TA; Santos, FM; Talvani, A; Torres, RM | 1 |
| Chou, SC; Ji, X; Kleiter, MM; Lee, DY; Malarkey, DE; Raleigh, JA; Thrall, DE | 1 |
| Brown, JM; White, RA; Workman, P | 1 |
| Creasey, WA; Thrall, DE | 1 |
| White, RA; Workman, P | 1 |
| Calkins, DP; McEntee, MC; Raleigh, JA; Thrall, DE; Zeman, EM | 1 |
| Cline, JM; Raleigh, JA; Rosner, GL; Thrall, DE | 2 |
| Harvey, C; Sarkiala, E | 1 |
| Azuma, C; Raleigh, JA; Thrall, DE | 1 |
| Azuma, C; McEntee, MC; Raleigh, JA; Rosner, GL; Thrall, DE | 1 |
| Bleehen, NM; Owen, LN; White, RA; Workman, P | 1 |
| Cline, JM; Franko, AJ; Page, RL; Raleigh, JA; Thrall, DE | 1 |
| Abbitt, B; Eugster, AK; Huey, RL; Syler, J | 1 |
1 review(s) available for azomycin and Canine Diseases
| Article | Year |
|---|---|
Systemic antimicrobials in the treatment of periodontitis in dogs.
Topics: Animals; Anti-Bacterial Agents; Dog Diseases; Dogs; Nitroimidazoles; Periodontitis; Quinolines | 1993 |
14 other study(ies) available for azomycin and Canine Diseases
| Article | Year |
|---|---|
Metabolic correlates of tumour hypoxia in malignant canine mammary carcinoma.
Topics: Animals; Dog Diseases; Dogs; Female; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Immunohistochemistry; Mammary Neoplasms, Animal; Nitroimidazoles; Oxygen Consumption; Radiation-Sensitizing Agents; Staining and Labeling | 2011 |
Cardiomyopathy prognosis after benznidazole treatment in chronic canine Chagas' disease.
Topics: Animal Experimentation; Animals; Antiprotozoal Agents; Chagas Cardiomyopathy; Chronic Disease; DNA, Protozoan; Dog Diseases; Dogs; Heart; Nitroimidazoles; Parasitemia; Prognosis; Trypanosoma cruzi | 2012 |
A comparison of oral and intravenous pimonidazole in canine tumors using intravenous CCI-103F as a control hypoxia marker.
Topics: Administration, Oral; Animals; Area Under Curve; Cell Hypoxia; Cell Line; Cricetinae; Cricetulus; Dog Diseases; Dogs; Feasibility Studies; Hydrogen-Ion Concentration; Injections, Intravenous; Neoplasms; Nitroimidazoles | 2006 |
The pharmacokinetics and tumor and neural tissue penetrating properties of SR-2508 and SR-2555 in the dog--hydrophilic radiosensitizers potentially less toxic than misonidazole.
Topics: Administration, Oral; Animals; Biological Availability; Dog Diseases; Dogs; Drug Evaluation, Preclinical; Etanidazole; Female; Injections, Intravenous; Kinetics; Male; Misonidazole; Neoplasms; Nervous System; Nitroimidazoles; Radiation-Sensitizing Agents; Structure-Activity Relationship | 1980 |
Pharmacokinetic and anti-tumor studies with the radiosensitizer misonidazole in dogs with spontaneous fibrosarcomas.
Topics: Animals; Dog Diseases; Dogs; Fibrosarcoma; Mandibular Neoplasms; Maxillary Neoplasms; Misonidazole; Mouth Neoplasms; Nitroimidazoles; Palate, Soft | 1982 |
Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-Ro-9963) in dogs.
Topics: Animals; Biological Availability; Dog Diseases; Dogs; Half-Life; Kinetics; Male; Misonidazole; Neoplasms; Nitroimidazoles | 1980 |
Distribution of hypoxia and proliferation associated markers in spontaneous canine tumors.
Topics: Animals; Biomarkers, Tumor; Biopsy; Carcinoma, Basal Cell; Cell Division; Cell Hypoxia; Dog Diseases; Dogs; Immunohistochemistry; Nitroimidazoles; Proliferating Cell Nuclear Antigen; Tumor Cells, Cultured | 1995 |
Distribution of the hypoxia marker CCI-103F in canine tumors.
Topics: Animals; Cell Hypoxia; Dog Diseases; Dogs; Female; Male; Neoplasms; Nitroimidazoles | 1994 |
Quantification of CCI-103F labeling heterogeneity in canine solid tumors.
Topics: Analysis of Variance; Animals; Biomarkers; Cell Hypoxia; Dog Diseases; Dogs; Neoplasms; Nitroimidazoles; Oxygen; Reproducibility of Results | 1997 |
Longevity of pimonidazole adducts in spontaneous canine tumors as an estimate of hypoxic cell lifetime.
Topics: Animals; Cell Survival; DNA Adducts; DNA, Neoplasm; Dog Diseases; Dogs; Hypoxia; Neoplasms; Nitroimidazoles | 1997 |
Hypoxia marker labeling in tumor biopsies: quantification of labeling variation and criteria for biopsy sectioning.
Topics: Animals; Biopsy; Cell Hypoxia; Dog Diseases; Dogs; Neoplasms; Nitroimidazoles | 1997 |
The penetration of misonidazole into spontaneous canine tumours.
Topics: Adenocarcinoma; Anesthesia, Intravenous; Animals; Carcinoma, Squamous Cell; Disease Models, Animal; Dog Diseases; Dogs; Female; Fibrosarcoma; Half-Life; Lymphoma, Non-Hodgkin; Male; Mammary Glands, Animal; Meningioma; Misonidazole; Neoplasms; Nitroimidazoles; Osteosarcoma; Pentobarbital | 1979 |
Immunohistochemical detection of a hypoxia marker in spontaneous canine tumours.
Topics: Animals; Cell Hypoxia; Dog Diseases; Dogs; Immunohistochemistry; Neoplasms; Nitroimidazoles; Staining and Labeling | 1990 |
Treatment of giardiasis in adult Greyhounds, using ipronidazole-medicated water.
Topics: Animals; Dog Diseases; Dogs; Giardiasis; Ipronidazole; Nitroimidazoles | 1986 |